Universitätsklinikum Erlangen, Strahlenklinik
Erlangen, Bavaria, 91054, Germany
Location status: Recruiting
NCT Number: NCT06367257
Patients with head and neck cancer requiring definitive or adjuvant radio(chemo)therapy can take part in the study. The aim is to record the nutritional status and diet of the patients during the trial and regularly at a period of 8 weeks after irradiation and to reduce the rate of weight loss and malnutrition.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Erlangen, Bavaria, 91054, Germany
Location status: Recruiting
Patients with head and neck cancer requiring definitive or adjuvant radio(chemo)therapy can take part in the study. The aim is to record the nutritional status and diet of the patients during the trial and regularly at a period of 8 weeks after irradiation and to reduce the rate of weight loss and malnutrition.
Patients in the experimental arm receive the daily reminder message via app (Emento) that they should pay attention to adequate caloric intake. In addition, these patients receive 3 screening questions about their current health and nutritional status twice a week.
In case of relevant deterioration (any negative value in the screening questions is explained under study procedure), additional further questions are asked, which are specifically aimed at the side effects of the tumor therapy (mainly dysphagia, pain). The answers will be transmitted to the radiation clinic.
If a question is answered positively, this is reported to the radiotherapy clinic on the one hand and on the other hand, the patient is asked to consult the doctor in the clinic as soon as possible.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Conducting patient surveys with app
supportive care during and after radio(chemo)therapy according to hospial standards
Time frame: during trial, about 24 months
Time frame: during trial, about 24 months
Time frame: during trial, about 24 months
Time frame: during trial, about 24 months
Time frame: during trial, about 24 months
Time frame: during trial, about 24 months
Time frame: during trial, about 24 months
Time frame: during trial, about 24 months
Time frame: during trial, about 24 months
Time frame: during trial, about 24 months
Time frame: during trial, about 24 months
Contact information is provided by the study sponsor or research team.
University of Erlangen-Nürnberg Medical School
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04747054
Carcinoma, Carcinoma, Squamous Cell
Avignon, France
View Trial DetailsNCT07276399
Carcinoma, Carcinoma, Squamous Cell
Chandler, Arizona, United States
View Trial DetailsNCT07219212
Carcinoma, Carcinoma, Squamous Cell
Birmingham, Alabama, United States
View Trial DetailsNCT04389632
Adenocarcinoma Of Esophagus, Adnexal Diseases
Anchorage, Alaska, United States
View Trial Details